Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite digestive proteases are enzymes responsible for the hydrolysis of host proteins, primarily to provide essential amino acids for parasite growth, development, and reproduction. These proteases, comprising cysteine, serine, and aspartic families, perform critical roles in nutrient acquisition, tissue invasion, immune evasion, and overall pathogenicity. Their central roles in parasite biology and disease make them validated targets for drug and vaccine development, and a focus of extensive biochemical, structural, and therapeutic research[2][4][5][8]. Inhibitors that block digestive protease activity have demonstrated efficacy in preclinical models, and specific protease antigens are being trialed as vaccine candidates. Safety and specificity remain key therapeutic challenges owing to the broad conservation of protease families in both parasite and host[5][7].
Protease inhibition (blocking activity—starving parasite of nutrients or impairing invasion)\nImmunization targeting protease antigens (eliciting host antibody responses to neutralize enzyme function)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite digestive protease (null).